DFC
DB Fitzpatrick & Co’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Buy |
4,352
+47
| +1% | +$18.3K | 1.5% | 12 |
|
|
2025
Q1 | $1.87M | Sell |
4,305
-311
| -7% | -$135K | 1.78% | 6 |
|
|
2024
Q4 | $1.7M | Buy |
4,616
+581
| +14% | +$214K | 1.57% | 14 |
|
|
2024
Q3 | $2.1M | Buy |
4,035
+305
| +8% | +$159K | 1.84% | 9 |
|
|
2024
Q2 | $2.02M | Sell |
3,730
-29
| -0.8% | -$15.7K | 1.87% | 6 |
|
|
2024
Q1 | $1.95M | Buy |
3,759
+136
| +4% | +$70.5K | 1.79% | 10 |
|
|
2023
Q4 | $1.71M | Sell |
3,623
-175
| -5% | -$82.5K | 1.64% | 10 |
|
|
2023
Q3 | $1.65M | Buy |
3,798
+85
| +2% | +$37K | 1.77% | 8 |
|
|
2023
Q2 | $1.65M | Buy |
3,713
+263
| +8% | +$117K | 1.74% | 10 |
|
|
2023
Q1 | $1.59M | Buy |
3,450
+922
| +36% | +$424K | 1.72% | 12 |
|
|
2022
Q4 | $1.3M | Buy |
2,528
+385
| +18% | +$197K | 1.49% | 19 |
|
|
2022
Q3 | $973K | Sell |
2,143
-672
| -24% | -$305K | 1.18% | 31 |
|
|
2022
Q2 | $1.36M | Buy |
2,815
+29
| +1% | +$14K | 1.5% | 17 |
|
|
2022
Q1 | $1.37M | Buy |
2,786
+46
| +2% | +$22.6K | 1.36% | 26 |
|
|
2021
Q4 | $1.27M | Buy |
+2,740
| New | +$1.27M | 1.19% | 29 |
|